<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38745394</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>12</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1468-1331</ISSN><JournalIssue CitedMedium="Internet"><Volume>31</Volume><Issue>11</Issue><PubDate><Year>2024</Year><Month>Nov</Month></PubDate></JournalIssue><Title>European journal of neurology</Title><ISOAbbreviation>Eur J Neurol</ISOAbbreviation></Journal><ArticleTitle>"Spanish flu," encephalitis lethargica, and COVID-19: Progress made, lessons learned, and directions for future research.</ArticleTitle><Pagination><StartPage>e16312</StartPage><MedlinePgn>e16312</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e16312</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1111/ene.16312</ELocationID><Abstract><AbstractText>One hundred years ago, an influenza pandemic swept across the globe that coincided with the development of a neurological condition, named "encephalitis lethargica" for the occurrence of its main symptom, the sudden onset of sleepiness that either developed into coma or gradually receded. Between 1917 and 1920, mortality of the flu was &gt;20 million and of encephalitis lethargica approximately 1 million. For lessons to be learned from this pandemic, it makes sense to compare it with the COVID-19 pandemic, which occurred 100&#x2009;years later. Biomedical progress had enabled testing, vaccinations, and drug therapies accompanied by public health measures such as social distancing, contact tracing, wearing face masks, and frequent hand washing. From todays' perspective, these public health measures are time honored but not sufficiently proven effective, especially when applied in the context of a vaccination strategy. Also, the protective effects of lockdowns of schools, universities, and other institutions and the restrictions on travel and personal visits to hospitals or old-age homes are not precisely known. Preparedness is still a demand for a future pandemic. Clinical trials should determine the comparative effectiveness of such public health measures, especially for their use as a combination strategy with vaccination and individual testing of asymptomatic individuals. It is important for neurologists to realize that during a pandemic the treatment possibilities for acute stroke and other neurological emergencies are reduced, which has previously led to an increase of mortality and suffering. To increase preparedness for a future pandemic, neurologists play an important role, as the case load of acute and chronic neurological patients will be higher as well as the needs for rehabilitation. Finally, new chronic forms of postviral disease will likely be added, as was the case for postencephalitic parkinsonism a century ago and now has occurred as long COVID.</AbstractText><CopyrightInformation>&#xa9; 2024 The Authors. European Journal of Neurology published by John Wiley &amp; Sons Ltd on behalf of European Academy of Neurology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Brainin</LastName><ForeName>Michael</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0001-8363-4962</Identifier><AffiliationInfo><Affiliation>Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Teuschl</LastName><ForeName>Yvonne</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-1755-7943</Identifier><AffiliationInfo><Affiliation>Department for Clinical Neurosciences and Preventive Medicine, Danube University Krems, Krems, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelpi</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0003-2948-4187</Identifier><AffiliationInfo><Affiliation>Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016456">Historical Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>05</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Neurol</MedlineTA><NlmUniqueID>9506311</NlmUniqueID><ISSNLinking>1351-5101</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D049673" MajorTopicYN="N">History, 20th Century</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010301" MajorTopicYN="N">Parkinson Disease, Postencephalitic</DescriptorName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007251" MajorTopicYN="N">Influenza, Human</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000266" MajorTopicYN="N">history</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention &amp; control</QualifierName><QualifierName UI="Q000628" MajorTopicYN="N">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID&#x2010;19</Keyword><Keyword MajorTopicYN="N">encephalitis lethargica</Keyword><Keyword MajorTopicYN="N">history of neurology</Keyword><Keyword MajorTopicYN="N">public health</Keyword></KeywordList><CoiStatement>None of the authors has any conflict of interest to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>4</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>4</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>6</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>5</Month><Day>15</Day><Hour>0</Hour><Minute>54</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>5</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38745394</ArticleId><ArticleId IdType="pmc">PMC11464390</ArticleId><ArticleId IdType="doi">10.1111/ene.16312</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>McKee M. Drawing Light from the Pandemic. WHO Geneva; 2021.</Citation></Reference><Reference><Citation>Barry John M. The Great Influenza. Penguin; 2005. &#xfc;p&#xdf;'&#xfc;&#xb4;&#xfc;&#xb4;.</Citation></Reference><Reference><Citation>
Centers for Disease Control and Prevention
. https://archive.cdc.gov/www_cdc_gov/flu/pandemic&#x2010;resources/1918&#x2010;pandemic&#x2010;h1n1.html#:~:text=The%20number%20of%20deaths%20was,occurring%20in%20the%20United%20States.&amp;text=Read%20about%20the%201918%20influenza,and%2065%20years%20and%20older. Accessed March 28, 2024</Citation></Reference><Reference><Citation>Ravenholt RT, Foege WH. 1918 influenza, encephalitis lethargica, parkinsonism. Lancet. 1982;2:860&#x2010;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">6126720</ArticleId></ArticleIdList></Reference><Reference><Citation>McCall S, Henry JM, Reid AH, Taubenberger JK. Influenza RNA not detected in archival brain tissue from acute encephalitis Lethargica cases or in postencephalitic Parkinson cases. J Neuropathol Exp Neurol. 2001;60:696&#x2010;704.</Citation><ArticleIdList><ArticleId IdType="pubmed">11444798</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffman LA, Vilensky JA. Encephalitis lethargica: 100&#x2009;years after the epidemic. Brain. 2017;140(8):2246&#x2010;2251. doi:10.1093/brain/awx177</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awx177</ArticleId><ArticleId IdType="pubmed">28899018</ArticleId></ArticleIdList></Reference><Reference><Citation>McCall S, Vilensky JA, Gilman S, Taubenberger JK. The relationship between encephalitis lethargica and influenza: a critical analysis. J Neurovirol. 2008;14(3):177&#x2010;185. doi:10.1080/13550280801995445</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280801995445</ArticleId><ArticleId IdType="pmc">PMC2778472</ArticleId><ArticleId IdType="pubmed">18569452</ArticleId></ArticleIdList></Reference><Reference><Citation>Von Economo C. Encephalitis lethargica. Wien Klin Wschr. 1917;30:581&#x2010;585.</Citation></Reference><Reference><Citation>Von Economo C. Die Encephalitis Lethargica. Franz Deuticke, Leipzig und Wien. 1917.</Citation></Reference><Reference><Citation>Van Bogaert VL, Theodorides J: Constantin von Economo . The Man and the Scientist. Verlag der &#xd6;sterreichischen Akademie der Wissenschaften. Wien. 1979.</Citation></Reference><Reference><Citation>Von Economo C. Die Enzephalitis Lethargica. Ihre Nachkrankheiten und Behandlung. Deuticke. 1929.</Citation></Reference><Reference><Citation>Litvan II, Jankovic J, Goetz CG, et&#xa0;al. Accuracy of the clinical diagnosis of postencephalitic parkinsonism: a clinicopathologic study. Eur J Neurol. 1998;5(5):451&#x2010;457. doi:10.1046/j.1468-1331.1998.550451.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1468-1331.1998.550451.x</ArticleId><ArticleId IdType="pubmed">10210873</ArticleId></ArticleIdList></Reference><Reference><Citation>Vilensky JA, Gilman S, McCall S. Does the historical literature on encephalitis lethargica support a simple (direct) relationship with postencephalitic parkinsonism? Mov Disord. 2010. Jul 15;25(9):1124&#x2010;1130. doi:10.1002/mds.22991</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mds.22991</ArticleId><ArticleId IdType="pubmed">20629127</ArticleId></ArticleIdList></Reference><Reference><Citation>Cadar D, Jellinger KA, Riederer P, Strobel S, Monoranu CM, Tappe D. No metagenomic evidence of causative viral pathogens in PostencephaliticParkinsonism following encephalitis Lethargica. Microorganisms. 2021;9(8):1716. doi:10.3390/microorganisms9081716</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms9081716</ArticleId><ArticleId IdType="pmc">PMC8398509</ArticleId><ArticleId IdType="pubmed">34442795</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent A. Encephalitis lethargica: part of a spectrum of poststreptococcal autoimmune diseases? Brain. 2004;127:2&#x2010;3.</Citation><ArticleIdList><ArticleId IdType="pubmed">14679031</ArticleId></ArticleIdList></Reference><Reference><Citation>Sacks O. Awakenings. EP Dutton/New York. 1983.</Citation></Reference><Reference><Citation>Sachs J, Abdul Karim SS, Aknin L, et&#xa0;al. The lancet commission on lessons for the future from the COVID&#x2010;19 pandemic. Lancet. 2022;400:1224&#x2010;1280.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9539542</ArticleId><ArticleId IdType="pubmed">36115368</ArticleId></ArticleIdList></Reference><Reference><Citation>Long B, Carius BM, Chavez S, et&#xa0;al. Clinical update on COVID&#x2010;19 for the emergency clinician: presentation and evaluation. Am J Emerg Med. 2022;54:46&#x2010;57.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8779861</ArticleId><ArticleId IdType="pubmed">35121478</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal A, Hunt B, Stegemann M, et&#xa0;al. A living guideline on drugs for Covid&#x2010;19. BMJ. 2020;370:M3379 (correction: April 25, 2022, last updated 10 Nov 2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">32887691</ArticleId></ArticleIdList></Reference><Reference><Citation>Horton R. The Covid&#x2010;19 Catastrophe. 2nd ed. Polity Press Medford; 2021.</Citation></Reference><Reference><Citation>L&#xe9;vy B&#x2010;H. The Virus in the Age of Madness. Yale University Press; 2020.</Citation></Reference><Reference><Citation>Liu L, Wang D, Brainin M, Elkind MSV, Leira E, Wang Y. Approaches to global stroke care during the COVID&#x2010;19 pandemic. Stroke Vasc Neurol. 2020;5:107&#x2010;109. doi:10.1136/svn-2020-000429</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/svn-2020-000429</ArticleId><ArticleId IdType="pmc">PMC7295857</ArticleId><ArticleId IdType="pubmed">32447298</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah SA, Robertson C, Sheikh A. Effects of the CPVID&#x2010;19 pandemic on NHS England waiting times for elective hospital care: a modelling study. Lancet. 2024;403:241&#x2010;243. doi:10.1016/S0140-6736(23)02744-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(23)02744-7</ArticleId><ArticleId IdType="pubmed">38219766</ArticleId></ArticleIdList></Reference><Reference><Citation>Global Coalition for Circulatory Health , Ferat LR, Forrest R, et&#xa0;al. Preventing the next pandemic: the case for investing in circulatory health &#x2013; a global coalition for circulatory health position paper. Glob Heart. 2021;16:66. doi:10.5334/gh.1077 eCollection 2021.</Citation><ArticleIdList><ArticleId IdType="doi">10.5334/gh.1077</ArticleId><ArticleId IdType="pmc">PMC8516006</ArticleId><ArticleId IdType="pubmed">34692391</ArticleId></ArticleIdList></Reference><Reference><Citation>Markus HS, Brainin M. COVID&#x2010;19 and stroke&#x2010;a global World Stroke Organization perspective. Int J Stroke. 2020;15:361&#x2010;364. doi:10.1177/1747493020923472</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/1747493020923472</ArticleId><ArticleId IdType="pubmed">32310017</ArticleId></ArticleIdList></Reference><Reference><Citation>Gelpi E, Klotz S, Beyerle M, et&#xa0;al. Multifactorial white matter damage in the acute phase and pre&#x2010;existing conditions may drive cognitive dysfunction after SARS&#x2010;CoV&#x2010;2 infection: neuropathology&#x2010;based evidence. Viruses. 2023. Mar 31;15(4):908. doi:10.3390/v15040908</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v15040908</ArticleId><ArticleId IdType="pmc">PMC10144140</ArticleId><ArticleId IdType="pubmed">37112888</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>